|
|
||||||||
Ann Thorac Surg 1993;56:1176-1177
© 1993 The Society of Thoracic Surgeons
Department of Cardiothoracic Surgery and Anesthesiology, University of Pittsburgh Pittsburgh, Pennsylvania USA
Accepted for publication February 9, 1993.
* Address reprint requests to Dr Armitage, Division of Cardiothoracic Surgery, University of Pittsburgh, 1084 Scaife Hall, Pittsburgh, PA 15216.
Heparin-coated perfusion systems have been used to perform cardiopulmonary bypass with decreased systemic heparin dosages. We report the case of a 60-year-old man with end-stage liver disease and severe aortic stenosis who underwent an aortic valve replacement without systemic anticoagulation, employing a heparin-coated perfusion system. In patients with a contraindication to systemic anticoagulation, cardiopulmonary bypass with a heparin-coated system without systemic anticoagulation may be a viable alternative.
This article has been cited by other articles:
![]() |
J. Butler, E. W. Murithi, V. L. Pathi, K. J.D. MacArthur, and G. A. Berg Duroflo II heparin bonding does not attenuate cytokine release or improve pulmonary function Ann. Thorac. Surg., July 1, 2002; 74(1): 139 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
C B. Mahoney Heparin-bonded circuits: clinical outcomes and costs Perfusion, May 1, 1998; 13(3): 192 - 204. [Abstract] [PDF] |
||||
![]() |
M. Yii, T. Gourlay, J. Fleming, B. Matata, and K. Taylor Evaluation of Carmeda(R) Bioactive Surface (CBAS(R)), Duraflo II and a novel nonspecific protease-modified surface using a new in vitro model simulating cardiopulmonary bypass Perfusion, May 1, 1996; 11(3): 229 - 240. [PDF] |
||||
![]() |
R. L. Korn, C. A. Fisher, E. R. Livingston, N. Stenach, S. J. Fishman, V. Jeevanandam, and V. P. Addonizio THE EFFECTS OF CARMEDA BIOACTIVE SURFACE ON HUMAN BLOOD COMPONENTS DURING SIMULATED EXTRACORPOREAL CIRCULATION J. Thorac. Cardiovasc. Surg., May 1, 1996; 111(5): 1073 - 1084. [Abstract] [Full Text] |
||||
![]() |
R. C. Gorman, N. P. Ziats, A. K. Rao, N. Gikakis, L. Sun, M. M. H. Khan, N. Stenach, S. Sapatnekar, V. Chouhan, J. H. Gorman III, et al. SURFACE-BOUND HEPARIN FAILS TO REDUCE THROMBIN FORMATION DURING CLINICAL CARDIOPULMONARY BYPASS J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 1 - 12. [Abstract] [Full Text] |
||||
![]() |
L. K. v. Segesser, B. M. Weiss, M. Pasic, E. Garcia, and M. I. Turina Risk and benefit of low systemic heparinization during open heart operations Ann. Thorac. Surg., August 1, 1994; 58(2): 391 - 398. [Abstract] [PDF] |
||||
![]() |
A. T. Cheung, S. K. Levin, S. J. Weiss, M. A. Acker, and N. Stenach Intracardiac thrombus: A risk of incomplete anticoagulation for cardiac operations Ann. Thorac. Surg., August 1, 1994; 58(2): 541 - 542. [Abstract] [PDF] |
||||
![]() |
J. Sierra-Quiroga, J. Rubio-Alvarez, D. D. Mufioz, and J. B. Garcia-Bengachen Aortic valve replacement with heparin-coated perfusion system Ann. Thorac. Surg., August 1, 1994; 58(2): 603 - 603. [PDF] |
||||
![]() |
R. D. Dowling, M. E. Brown, R. O. Whittington Jr, J. J. Quinlan, and J. M. Armitage Reply Ann. Thorac. Surg., August 1, 1994; 58(2): 603 - 603. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |